MetLife Investment Management’s Performant Healthcare Inc PHLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,693
Closed -$315K 2887
2025
Q3
$315K Sell
40,693
-2,129
-5% -$13.6K ﹤0.01% 2053
2025
Q2
$171K Buy
42,822
+7,890
+23% +$22.4K ﹤0.01% 2267
2025
Q1
$103K Buy
34,932
+8,326
+31% +$21.6K ﹤0.01% 2511
2024
Q4
$80.3K Buy
26,606
+2,507
+10% +$8.62K ﹤0.01% 2689
2024
Q3
$90.1K Sell
24,099
-17,692
-42% -$60.4K ﹤0.01% 2664
2024
Q2
$121K Buy
41,791
+14,910
+55% +$42.8K ﹤0.01% 2506
2024
Q1
$79K Sell
26,881
-8,785
-25% -$25.1K ﹤0.01% 2636
2023
Q4
$111K Hold
35,666
﹤0.01% 2555
2023
Q3
$80.6K Hold
35,666
﹤0.01% 2692
2023
Q2
$96.3K Buy
+35,666
New +$103K ﹤0.01% 2703

Other funds holding PHLT

MetLife Investment Management's PHLT Position: Q4 2025 in Review

MetLife Investment Management sold out of Performant Healthcare Inc (PHLT) in Q4 2025, closing a stake of 40,693 shares — an estimated $315K sold.

MetLife Investment Management first reported a position in PHLT in Q2 2023 and held it in 10 quarters. The position peaked at $315K in Q3 2025. 1 fund tracked by Wall St. Rank holds PHLT as of Q4 2025.

  • MetLife Investment Management reported no remaining Performant Healthcare Inc position as of Q4 2025 after selling out during the quarter.
  • MetLife Investment Management sold 40,693 Performant Healthcare Inc shares in Q4 2025, an estimated $315K.
  • MetLife Investment Management first reported a position in Performant Healthcare Inc in Q2 2023 and held it in 10 quarters.
  • MetLife Investment Management's Performant Healthcare Inc position peaked at $315K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Performant Healthcare Inc as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.